Instil Bio, Inc.
TILNasdaqCIK 1789769HealthcareFiscal year ends Dec 31
Reports and events: 101 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1317:00 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001789769-26-000057 |
| 2026-08-1316:59 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001789769-26-000055 |
| 2026-06-1116:30 ET | 8-K | 5.07 Shareholder vote results | 0001789769-26-000048 |
| 2026-05-1508:31 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001789769-26-000045 |
| 2026-05-1508:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001789769-26-000044 |
| 2026-04-2416:20 ET | DEF 14A | Proxy statementPeriod 2026-06-11 | 0001789769-26-000030 |
| 2026-04-0308:00 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001789769-26-000024 |
| 2026-03-2707:05 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001789769-26-000019 |
| 2026-03-2707:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001789769-26-000018 |
| 2026-01-0617:00 ET | 8-K | 1.02 Termination of a material agreement | 0001789769-26-000004 |
| 2025-11-1307:08 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001789769-25-000094 |
| 2025-11-1307:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001789769-25-000092 |
| 2025-08-1307:06 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001789769-25-000081 |
| 2025-08-1307:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001789769-25-000079 |
| 2025-07-3116:31 ET | 8-K | 8.01 Other events | 0001789769-25-000074 |
| 2025-05-2817:16 ET | 8-K | 5.07 Shareholder vote results | 0001789769-25-000062 |
| 2025-05-2717:03 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001789769-25-000059 |
| 2025-05-2206:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001789769-25-000054 |
| 2025-05-1307:06 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001789769-25-000051 |
| 2025-05-1307:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001789769-25-000050 |
| 2025-04-1416:30 ET | DEF 14A | Proxy statementPeriod 2025-05-28 | 0001789769-25-000034 |
| 2025-03-3117:38 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001789769-25-000024 |
| 2025-03-0407:42 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001789769-25-000017 |
| 2025-03-0407:14 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001789769-25-000012 |
| 2025-01-1407:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001789769-25-000003 |
| 2024-12-2317:00 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation | 0001789769-24-000106 |
| 2024-11-1307:39 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001789769-24-000103 |
| 2024-11-1307:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001789769-24-000100 |
| 2024-10-2218:21 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-241198 |
| 2024-09-1606:02 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-040396 |
| 2024-09-0617:02 ET | 8-K | 2.05 Exit or disposal costs | 0001628280-24-039726 |
| 2024-08-1517:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001789769-24-000090 |
| 2024-08-1317:16 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001789769-24-000086 |
| 2024-08-1317:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001789769-24-000082 |
| 2024-08-0117:00 ET | 8-K | 1.01 Entry into a material agreement | 0001789769-24-000077 |
| 2024-07-1117:00 ET | 8-K | 1.01 Entry into a material agreement | 0001789769-24-000075 |
| 2024-06-1717:02 ET | 8-K | 5.07 Shareholder vote results | 0001789769-24-000070 |
| 2024-05-1007:10 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001789769-24-000059 |
| 2024-05-1007:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001789769-24-000057 |
| 2024-04-2616:04 ET | DEF 14A | Proxy statementPeriod 2024-06-13 | 0001789769-24-000051 |
| 2024-04-2616:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001789769-24-000050 |
| 2024-03-2117:05 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001789769-24-000036 |
| 2024-03-2117:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001789769-24-000034 |
| 2024-02-1416:08 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001789769-24-000027 |
| 2024-01-1807:01 ET | 8-K | 8.01 Other events | 0001789769-24-000020 |
| 2024-01-1617:00 ET | 8-K | 2.05 Exit or disposal costs; 8.01 Other events; 9.01 Financial statements and exhibits | 0001789769-24-000018 |
| 2023-12-0817:00 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001789769-23-000100 |
| 2023-11-2707:13 ET | 8-K | 7.01 Regulation FD disclosure | 0001789769-23-000095 |
| 2023-11-1317:27 ET | 10-Q/A | Quarterly report, amendedPeriod 2023-09-30 | 0001789769-23-000093 |
| 2023-11-1317:03 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001789769-23-000091 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.